New York City’s startup ecosystem posted one of its strongest months on record in March 2026, raising $3.94 billion across 97 deals — a 293.6% surge year-over-year compared to the $1.0 billion raised in March 2025 and a 55.6% increase month-over-month from February 2026’s $2.53B. The exceptional performance was driven by a concentration of mega-rounds at the late stage, with eight companies raising $100M or more accounting for more than half of total capital deployed. Kalshi’s $1 billion late-stage round — the largest NYC deal in recent memory — anchored the month and signaled investor conviction in prediction markets as a category with durable defensibility.
🔑 Key Insights
- $3.94B raised in NYC across 97 deals in March 2026 — one of the strongest months on record for the ecosystem.
- Capital deployment surged +55.6% month-over-month from February 2026’s $2.53B, with deal count rising 27.6% (97 vs. 76 deals) — driven by broad-based activity across all stages.
- Year-over-year capital deployment surged +293.6% versus $1.0B in March 2025, propelled by mega-round concentration and late-stage investor appetite.
- Late-stage rounds accounted for only 15.5% of deals but captured 53.9% of total capital ($2.12B across 15 rounds), led by Kalshi ($1B), Grafana Labs ($250M), and Grow Therapy ($150M).
- Eight mega-rounds of $100M or more closed in March, collectively totaling $2.00B (50.8% of the month) — signaling investor conviction in proven business models at scale.
- NYC captured 20.7% of all US venture capital in March 2026, with outsized share in Series A (39.8% of deals, 21.9% of capital) demonstrating the city’s strength in early-scale company formation.
- AI companies accounted for 44 of 97 NYC deals (45.4%) and $1.27B in funding (32.2%), a notable moderation from recent months dominated by frontier model raises.
New York City Startup Funding — March 2026
March’s headline number was dominated by Kalshi’s $1 billion late-stage round, the prediction market platform’s capital raise representing 25.4% of the month’s total and the largest NYC deal in recent memory. The 55.6% capital increase over February alongside a 27.6% rise in deal count signals broad-based ecosystem momentum rather than concentration in a single mega-round. Beyond Kalshi, March saw major rounds from Grafana Labs ($250M), Grow Therapy ($150M), Cents ($140M), and ScaleOps ($130M) — all proven companies scaling rapidly in their respective categories.
The fintech and financial services sectors had an outstanding month, paced not only by Kalshi’s raise but also by Theo ($100M) and OpenFX ($94M), reflecting New York’s continued dominance in financial innovation. Infrastructure also stood out: Grafana Labs’ $250M late-stage round reinforced the city’s position in cloud data services and observability, while ScaleOps ($130M) captured investor attention in the AI infrastructure and cloud optimization space.
NYC Funding by Round Type — March 2026
| Round Type | # Deals | Capital Raised | % of Total $ | Median Deal | Avg Deal |
|---|---|---|---|---|---|
| Early-Stage | 25 | $173.2M | 4.4% | $5.0M | $6.9M |
| Series A | 43 | $1.05B | 26.7% | $20.0M | $24.4M |
| Series B | 14 | $592.0M | 15.0% | $31.0M | $42.3M |
| Late-Stage | 15 | $2.12B | 53.9% | $50.0M | $141.3M |
| Total | 97 | $3.94B | 100% | $20.0M | $40.6M |
The stage distribution reveals a market driven by late-stage capital but supported by robust activity across all tiers. The 15 late-stage rounds averaged $141.3M each and captured 53.9% of total capital — a pattern consistent with investor appetite for companies that have demonstrated product-market fit and are now scaling aggressively. Series A activity was particularly strong with 43 deals raising $1.05B combined, representing the largest deal count of any stage and signaling a healthy pipeline of companies progressing through NYC’s venture ecosystem.
Series B remained steady at 14 deals totaling $592M, with an average round size of $42.3M reflecting mid-stage companies scaling their go-to-market motions. Early-stage activity, while representing just 4.4% of capital ($173.2M across 25 deals), continues to form the foundational layer of the ecosystem — these companies will represent the Series A and B pipeline of 2027 and beyond.
Top 10 NYC Venture Capital Deals — March 2026
| # | Company | Amount | Round | Sector |
|---|---|---|---|---|
| 1 | Kalshi | $1.00B | Late-Stage | Financial Exchanges / Prediction Markets |
| 2 | Grafana Labs | $250M | Late-Stage | Analytics / Cloud Data Services |
| 3 | Grow Therapy | $150M | Late-Stage | Health Care / Mental Health |
| 4 | Cents | $140M | Late-Stage | Business Process Automation / Point of Sale |
| 5 | ScaleOps | $130M | Late-Stage | AI Infrastructure / Cloud Computing |
| 6 | Oasis Security | $120M | Series B | Identity Management / Network Security |
| 7 | Dash0 | $110M | Series B | Agentic AI / IT Infrastructure |
| 8 | Theo | $100M | Late-Stage | Financial Services / Trading Platform |
| 9 | OpenFX | $94M | Series A | Embedded Systems / Financial Exchanges |
| 10 | Sage | $65M | Late-Stage | Elder Care / Nursing and Residential Care |
AI and Emerging Sectors
AI companies raised $1.27B across 44 deals in March 2026, representing 32.2% of total capital. While this is a significant share, it marks a notable shift from the AI-dominated narratives of recent months. The capital is flowing to applied AI infrastructure — companies like ScaleOps (cloud optimization), Dash0 (agentic AI for IT infrastructure), and Normal Computing (AI infrastructure) — rather than frontier model development.
Beyond AI, March saw meaningful activity in financial services and fintech (Kalshi, Theo, OpenFX), healthcare (Grow Therapy, Sage, Waiv), and cybersecurity (Oasis Security). The diversification of capital across sectors is a healthy sign for the ecosystem — it suggests that the market is backing a wide range of business models and not overly concentrated in a single theme.
NYC vs. US National Comparison by Round Type — March 2026
| Round Type | NYC | US Total | NYC % |
|---|---|---|---|
| Early-Stage | |||
| Capital Raised | $173.2M | $1.43B | 12.1% |
| Deal Count | 25 | 317 | 7.9% |
| Average Deal | $6.9M | $4.5M | — |
| Median Deal | $5.0M | $2.0M | — |
| Series A | |||
| Capital Raised | $1.05B | $4.79B | 21.9% |
| Deal Count | 43 | 108 | 39.8% |
| Average Deal | $24.4M | $44.4M | — |
| Median Deal | $20.0M | $23.9M | — |
| Series B | |||
| Capital Raised | $592.0M | $3.92B | 15.1% |
| Deal Count | 14 | 45 | 31.1% |
| Average Deal | $42.3M | $87.2M | — |
| Median Deal | $31.0M | $42.0M | — |
| Late-Stage | |||
| Capital Raised | $2.12B | $8.91B | 23.8% |
| Deal Count | 15 | 45 | 33.3% |
| Average Deal | $141.3M | $197.9M | — |
| Median Deal | $50.0M | $60.0M | — |
| Overall Total | $3.94B | $19.06B | 20.7% |
| Deal Count | 97 | 630 | 15.4% |
| Average Deal | $40.6M | $37.0M | — |
| Median Deal | $20.0M | $6.0M | — |
NYC’s share of national venture capital varies significantly by stage. The city captured 21.9% of all US Series A capital and an impressive 39.8% of Series A deals in March 2026, reflecting NYC’s position as a dominant force in early-scale company formation. Late-stage activity showed similar strength, with NYC accounting for 23.8% of late-stage capital across 33.3% of deals — driven by mega-rounds like Kalshi’s $1B and Grafana Labs’ $250M that demonstrate the city’s ability to support companies scaling to market leadership. The city’s 20.7% overall share of classified US venture capital (up from 13.8% in February) underscores the ecosystem’s momentum.
National Context
While NYC posted one of its strongest months on record, the national US venture market saw $19.06B raised across 630 classified deals in March 2026 (with an additional $4.02B across 177 unclassified rounds). This represents a significant year-over-year decline from March 2025’s $53.5B total, which was heavily influenced by OpenAI’s $40B raise. Excluding that single mega-deal, the national market is effectively flat year-over-year, signaling stabilization rather than contraction.
The March performance underscores New York’s position as the nation’s second-largest venture hub and its ability to generate outsized deal activity independent of West Coast mega-rounds. The city’s share of national venture capital continues to grow, driven by concentration in financial services, healthcare, and applied AI infrastructure — sectors where NYC has both talent density and regulatory expertise.
Stay Ahead of NYC Tech
Join 100K+ Email List Contacts receiving daily insights on NYC’s startup ecosystem, VC funding trends, and emerging companies.
Methodology
All data sourced from Crunchbase. Deal counts and funding totals reflect announced and disclosed venture capital transactions with a last funding date in March 2026. Round type classifications follow a standardized four-category taxonomy: Early-Stage (pre-seed through seed), Series A, Series B, and Late-Stage (Series C and beyond, including growth and corporate rounds). AI company identification was applied using pattern matching across company descriptions, industry tags, and organization names. Year-over-year comparisons reference March 2025 figures of $1.0B. Month-over-month comparisons reference February 2026 figures of $2.53B across 76 deals. US national figures reference March 2026 classified totals of $19.06B across 630 deals. NYC figures represent companies headquartered in the New York City metropolitan area.
AlleyWatch is the leading media property covering the New York City startup and venture capital ecosystem. AlleyWatch publishes news, analysis, and data on funding activity, founder stories, and market trends shaping one of the world’s most dynamic innovation hubs.
